Oscar Health (NYSE:OSCR) Shares Down 3.6% – Should You Sell?

Oscar Health, Inc. (NYSE:OSCR) traded down 3.6% during mid-day trading on Friday . The company traded as low as $16.18 and last traded at $16.19. 2,941,235 shares changed hands during trading, a decline of 8% from the average session volume of 3,204,464 shares. The stock had previously closed at $16.80.

Analyst Ratings Changes

A number of research analysts have issued reports on the company. Piper Sandler reissued an “overweight” rating and set a $28.00 price objective on shares of Oscar Health in a report on Tuesday, September 10th. UBS Group assumed coverage on Oscar Health in a report on Monday, October 7th. They set a “neutral” rating and a $23.00 price objective for the company. Three equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $24.00.

Oscar Health Stock Performance

The company has a market capitalization of $3.96 billion, a price-to-earnings ratio of -125.76, a price-to-earnings-growth ratio of 34.83 and a beta of 1.62. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. The stock has a 50 day moving average price of $19.00 and a two-hundred day moving average price of $18.27.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. The firm had revenue of $2.20 billion during the quarter, compared to analyst estimates of $2.13 billion. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. The company’s revenue was up 44.6% on a year-over-year basis. During the same period last year, the company earned ($0.07) earnings per share. On average, analysts predict that Oscar Health, Inc. will post 0.01 EPS for the current fiscal year.

Insider Buying and Selling

In related news, insider Mario Schlosser sold 3,198 shares of Oscar Health stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the sale, the insider now directly owns 76,982 shares in the company, valued at $1,384,906.18. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, EVP Ranmali Bopitiya sold 36,175 shares of Oscar Health stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $650,788.25. Following the completion of the sale, the executive vice president now directly owns 251,885 shares in the company, valued at $4,531,411.15. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Mario Schlosser sold 3,198 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the transaction, the insider now owns 76,982 shares of the company’s stock, valued at $1,384,906.18. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 169,569 shares of company stock worth $3,007,069 over the last three months. 25.11% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Oscar Health

Several institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in shares of Oscar Health by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock valued at $216,846,000 after purchasing an additional 337,850 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Oscar Health by 153.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock valued at $59,156,000 after purchasing an additional 2,409,160 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Oscar Health by 31.7% during the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock valued at $61,478,000 after purchasing an additional 934,600 shares in the last quarter. First Light Asset Management LLC lifted its holdings in shares of Oscar Health by 117.3% during the 1st quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company’s stock valued at $31,265,000 after purchasing an additional 1,134,919 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its holdings in shares of Oscar Health by 32.9% during the 2nd quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock valued at $32,368,000 after purchasing an additional 507,009 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.